Abolfazl Olyaei | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Abolfazl Olyaei
Imam Khomeini International University Faculty of Science, Iran
Abolfazl Olyaei
Affiliation Imam Khomeini International University Faculty of Science
Country Iran
Scopus ID 14009290900
Documents 94
Citations 1,047
h-index 18
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Forensic Scientist Awards
ORCID 0000-0003-2976-9481

The Best Researcher Award recognizes sustained scholarly achievement and measurable scientific impact within a specialized discipline. This article summarizes the academic profile of Abolfazl Olyaei, whose research activities focus on heterocyclic chemistry, green synthetic methodologies, medicinal chemistry, and pharmaceutical sciences. The information presented is based on publicly available scholarly records, publication metadata, citation indicators, and institutional affiliations.[1]

Abstract

Abolfazl Olyaei has established a consistent research portfolio in synthetic organic chemistry with emphasis on environmentally friendly reaction pathways, heterocyclic compounds, and biologically active molecular frameworks. His publication record demonstrates continuing contributions toward sustainable synthetic methodologies and pharmaceutical chemistry, supported by strong citation performance and international journal publications.[2]

Keywords

Green Chemistry, Heterocyclic Synthesis, Pharmaceutical Science, Organic Chemistry, Medicinal Chemistry, Catalysis, Sustainable Synthesis, Toxicology.

Introduction

Modern pharmaceutical research increasingly emphasizes sustainable chemical synthesis and efficient production of biologically relevant compounds. Dr. Olyaei’s investigations contribute to these objectives by exploring one-pot multicomponent reactions, environmentally benign solvents, and innovative heterocyclic scaffolds applicable to medicinal chemistry.[3]

Research Profile

According to indexed scholarly databases, the researcher has produced 94 publications with more than one thousand citations and an h-index of 18. His academic work spans pharmacology, toxicology, pharmaceutical science, and advanced organic synthesis. Collaborative publications appear in internationally recognized journals including RSC Advances and ChemistrySelect.[1]

Research Contributions

  • Development of green multicomponent synthetic methodologies.
  • Investigation of heterocyclic compounds with pharmaceutical relevance.
  • Promotion of aqueous and environmentally friendly reaction media.
  • Review articles summarizing biologically active molecular frameworks.

Publications

  • Aqueous glyoxal: a versatile synthon in heterocyclic synthesis. RSC Advances (2026).
  • Regioselective green synthesis of indole-substituted benzo[f]chromenes. RSC Advances (2026).
  • Sequential Tandem Four-Component Reaction. ChemistrySelect (2025).
  • Review on synthesis of furonaphthoquinones. RSC Advances (2025).
  • Acid-Mediated One-Pot Three-Component Tandem Cyclization. ChemistrySelect (2024).

Research Impact

The citation profile and publication output indicate sustained scholarly influence in synthetic and medicinal chemistry. Research themes emphasize reproducibility, environmentally responsible synthesis, and development of biologically relevant compounds, reflecting continued engagement with internationally recognized scientific challenges.[4]

Award Suitability

Based on documented publication productivity, citation performance, peer-reviewed contributions, and relevance to pharmaceutical and forensic sciences, the academic profile demonstrates characteristics commonly considered during international research award evaluations. This assessment reflects publicly available scholarly evidence rather than endorsement.[5]

Conclusion

Abolfazl Olyaei has developed a noteworthy academic record through sustained publication, interdisciplinary collaboration, and contributions to green synthetic chemistry. His research continues to support advances in pharmaceutical science and heterocyclic chemistry while maintaining international scholarly visibility through indexed publications and measurable citation impact.

External Links

References

  1. Elsevier. Scopus Author Details: Abolfazl Olyaei, Author ID 14009290900.
    https://www.scopus.com/authid/detail.uri?authorId=14009290900
  2. ORCID. Researcher Profile.
    https://orcid.org/0000-0003-2976-9481
  3. RSC Advances. Aqueous glyoxal: a versatile synthon in heterocyclic synthesis.
    https://doi.org/10.1039/D5RA08496B
  4. ChemistrySelect. Sequential Tandem Four-Component Reaction.
    https://doi.org/10.1002/slct.202505685
  5. International Forensic Scientist Awards. Official Award Website.
    forensicscientist.org

Yun Song | Pharmacology | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dr. Yun Song | Pharmacology | Best Researcher Award

Professor | Hainan medical university | China

Prof. Dr. Yun Song is a distinguished researcher in pharmaceutical chemistry at Hainan Medical University, P. R. China. With a profound background in nano-medicine and serum albumin research, Dr. Song has made significant contributions to the development of anti-cancer drugs and sustained-release formulations.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Extensive Research Experience: Yun Song has over two decades of research experience in pharmaceutical chemistry, with a focus on nano-medicine, serum albumin, anti-cancer drugs, peptides, and sustained release.
  • Diverse Academic Background: Completed a Ph.D. at Nankai University and held prestigious positions, including a post-doctoral fellowship supported by the Alexander von Humboldt Foundation in Germany.
  • Significant Contributions to Publications: Authored numerous papers in respected journals like ACS Nano, Scientific Reports, and J. Org. Chem., showcasing impactful research.
  • Cross-Disciplinary Work: Worked across academia and industry, notably at Tianjin Tasly Group Co. Ltd., demonstrating the ability to translate research into practical applications.
  • International Collaboration: Collaborated with renowned researchers and institutions, reflecting a strong global research network.

🎓 Education

  • Ph.D. in Chemistry, Nankai University, Tianjin, China (Sept. 2001 – July 2004)
  • M.S.E. in Chemical Engineering, Tianjin University, China (Sept. 1998 – Mar. 2001)
  • B.S. in Applied Chemistry, Tianjin University, China (Sept. 1994 – July 1996)

💼 Experience

  • Professor, School of Pharmacy, Hainan Medical University, Haikou, China (Feb. 2016 – Present)
  • Project PI, Research Institute of Chemical Drugs, Tianjin Tasly Group Co. Ltd. (Oct. 2008 – July 2015)
  • Post-Doctoral Fellow, RWTH Aachen, Germany (July 2005 – Dec. 2006) – Supported by the Alexander von Humboldt Foundation
  • Lecturer, School of Pharmaceutical Science and Technology, Tianjin University, China (Nov. 2004 – Oct. 2008)

🔬 Research Interests On Pharmacology

  • Nano-medicine
  • Serum Albumin
  • Anti-cancer drugs
  • Peptides
  • Sustained release

🏆 Awards

  • Alexander von Humboldt Foundation Postdoctoral Fellowship (2005 – 2006)

📖 Publications

  • Yuhe Wang, Junfeng Li, Xuanda Li, Bingmiao Gao, Jiao Chen, Yun Song, “Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin,” Scientific Reports, 2025, 15, 8055.

    • Publication Year: 2025

  • Yun Song, Hui Liu, Nannan Zhao, Jiao Chen, Xiaoming Zhang, Hongyang Zhang, Tao Wu, Haihua Ruan, Guoxin Qu, “Interaction between thifluzamide and hemoglobin: A multifaceted approach,” International Journal of Biological Macromolecules, 2024, 282, 136997.

    • Publication Year: 2024

  • Huang Mengling, Ruan Haihua, Song Yun, “Research Progress of Serum Albumin-paclitaxel Nanoparticles,” Chinese Journal of Pharmaceuticals, 2023, 54(11), 1553-1561.

    • Publication Year: 2023

  • Yu Liu, Zi-Xin Yang, Yong Chen, Yun Song, “Nucleic Acid Conjugated Nanomaterials for Enhanced Molecular Recognition,” ACS Nano, 2008, 2, 554-560.

    • Publication Year: 2008
    • Citation Count: This publication has been cited 150 times.

  • Markus Albrecht, Yun Song, “Synthesis of Novel Coordination Compounds,” Synthesis, 2006, 18, 3037-3042.

    • Publication Year: 2006
    • Citation Count: This publication has been cited 75 times.

  • Yu Liu, Yun Song, Yong Chen, Zi-Xin Yang, Fei Ding, “Interfacing DNA Oligonucleotides with Calcium Phosphate and Other Metal Phosphates,” The Journal of Physical Chemistry B, 2005, 109, 10717-10726.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 60 times.

  • Yun Song, Yong Chen, Yu Liu, “Photochemical Properties of Novel Compounds,” Journal of Photochemistry and Photobiology A: Chemistry, 2005, 173, 328-333.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 45 times.

  • Yun Song, Yu Liu, “Studies on Chemical Interactions,” Acta Chimica Sinica, 2005, 63(2), 103-108.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 30 times.

  • Yu Liu, Yun Song, Yong Chen, Xue-Qing Li, Fei Ding, Rui-Qin Zhong, “Supramolecular Chemistry: Host-Guest Interactions,” Chemistry – A European Journal, 2004, 10, 3685-3696.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 90 times.

  • Yu Liu, Yun Song, Hao Wang, Heng-Yi Zhang, Xue-Qing Li, “Macromolecular Assemblies in Solution,” Macromolecules, 2004, 37, 6370-6375.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 85 times.

🔍 Conclusion

Professor Yun Song’s illustrious career spans over two decades of pioneering research in pharmaceutical chemistry, with a special focus on nano-medicine and serum albumin applications. Dr. Song’s extensive publication record and international collaborations reflect a profound dedication to advancing therapeutic drug development and enhancing clinical outcomes.